44 pubs · 1,736 cites · h-index 15
This study proposes an Adaptive Genetic Algorithm (AGA) model for predicting training load in fencing. Training load is defined using external mechanical load collected from sensors and is categorized into six components: strength, aerobic, capacity, endurance, speed, agility, and flexibility. The study employs the publicly available Daily and Sports Activities dataset, which includes data from eight healthy adults (four females and four males, aged 20–30) performing 19 types of activities. Time-series segments are mapped to fencing-related load patterns for model training and evaluation. The proposed AGA dynamically adjusts the fitness function, crossover rate, and mutation rate. Its performance is compared with several models, including Deep Neural Network with Gated Recurrent Unit (DNN-GRU), Extreme Gradient Boosting (XGBoost), Long Short-Term Memory with Attention Mechanism (LSTM-Attn), Event Adversarial Neural Network (EANN), and Temporal Attention Graph Convolutional Network (TA-GCN). The results show that the AGA consistently outperformed all comparison methods in terms of prediction error and goodness-of-fit. For example, in endurance load prediction, the test set achieves an R 2 of 0.97 and an accuracy of 0.96. Time-series visualizations are used to analyze typical and extreme load segment, where extreme load is defined as time windows in which the predicted external load falls within the top decile. Overall, the findings demonstrate that the optimized AGA framework provides reliable training load predictions while maintaining computational efficiency. This approach offers a practical reference for data-driven training monitoring and training planning in fencing and related sports.
Experimental findings demonstrate altered cell cycle dynamics and increased drug sensitivity to dexamethasone in ALL cells with ikaros isoform 6 modulation, suggesting potential therapeutic targets.
Brain metastasis from colorectal cancer was more common in patients with HER2 amplification. Here, we document a 53-year-old male with HER2-amplified rectal cancer and brain metastases, treated with Trastuzumab Deruxtecan (T-Dxd, 5.4 mg/kg) plus bevacizumab (7.5 mg/kg) every three weeks as third line therapy. The patient achieved a partial response with a progression-free-survival of 7 months, highlighting the potential of T-Dxd. Adverse events included grade 3 thrombocytopenia, grade 2 neutropenia, and grade 1 fatigue. Our report emphasizes the rarity of brain metastases in colorectal cancer and illustrates a favorable response to T-Dxd plus bevacizumab.
Hematological parameters available on automated hematology analyzers have been shown to be useful indicators for hematological disorders. However, extensive studies especially in aplastic anemia for these indices are sparse. Our aim was to investigate the clinical utility of hematological parameters in aplastic anemia. The retrospective study included 146 patients with aplastic anemia and 150 normal controls matched in age and gender, where clinical characteristics and hematological parameters were classified and statistically analyzed. The study showed a statistical difference in the hematological parameters between aplastic anemia patients and controls. White blood cells, absolute neutrophil count, platelet, absolute reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, mean sphered cell volume, and light scattering reticulocyte count showed significant differences between non-severe aplastic anemia and severe aplastic anemia (p < 0.05). The analysis of the ROC curve showed that the hematological parameters were valuable for the differential diagnosis of severe aplastic anemia (areas under curve of white blood cell, absolute neutrophil count, platelet, absolute reticulocyte count, mean reticulocyte volume, immature reticulocyte fraction, mean sphered cell volume, light scatter reticulocytes were 0.620-0.859). Meanwhile, a combination of absolute neutrophil count, absolute reticulocyte count and mean sphered cell volume (AUC 0.893, 95% confidence interval 0.842-0.943, sensitivity 78.9%, specificity 85.7%) showed excellent precision for the differential diagnosis of severe aplastic anemia. Hematological parameters are readily available parameters that can be helpful to differentiate severe aplastic anemia from non-severe aplastic anemia. They may extend valuable prospects for clinical practice and research in aplastic anemia.
Background Bevacizumab is the representative drug in antiangiogenic therapy for lung cancer. However, it induced resistance in some neoplasm. Anlotinib, a novel multi-target tyrosine kinase inhibitor which has an inhibitory action on both angiogenesis and malignancy, is possible to reverse the resistance. Methods Transwell migration and invasion experiments of bevacizumab with or without anlotinib were conducted to verify the activated/inhibited ability of lung adenocarcinoma cells. We sequenced A549 cells with enhanced migration and invasion abilities after bevacizumab treatment, screened out the differentially expressed gene and further confirmed by western blot and q-PCR assays. We also investigated immunohistochemical staining of tumor tissue in mice and human lung adenocarcinoma. Results Bevacizumab facilitated migration and invasion of lung adenocarcinoma cells. Differentially expressed gene RGC32 was screened out. Bevacizumab upregulated the expression of RGC32, N-cadherin, and MMP2 through ERK-MAPK and PI3K-AKT pathways. Anlotinib downregulated their expression and reversed the effect of bevacizumab on A549 cells. In vivo experiments confirmed that higher-dose bevacizumab facilitated metastasis in tumor-bearing nude mice and upregulated the expression of RGC32, N-cadherin, and MMP2, whereas anlotinib abrogated its effect. Expression of both RGC32 and N-cadherin positively correlated with lymph node metastasis and stage in lung adenocarcinoma was found. Survival analysis revealed that higher expressions of RGC32 and N-cadherin were associated with poor progression-free survival and overall survival. Conclusions Bevacizumab may promote invasion and metastasis of lung adenocarcinoma cells by upregulating RGC32 through ERK-MAPK and PI3K-AKT pathways to promote epithelial–mesenchymal transition, whereas anlotinib reverses the effect. RGC32 and N-cadherin are independent prognostic factors in lung adenocarcinoma.
Surgical incision infection of multidrug-resistant microorganisms (e.g., methicillin-resistantStaphylococcus aureus, MRSA) is a severe cause of poor wound healing, which is prevalent in healthcare facilities and constitutes a huge infectious disease burden in the world. The purpose of this study is to investigate the medical application and possible mechanisms of the cold atmospheric plasma jet on infected wounds. In this article, the New Zealand rabbitin vivowound infected with MRSA is used as the wound healing animal model. The helium atmospheric-pressure dielectric-barrier-discharge (AP-DBD) plasma jet is employed to treat the wounds infected with MRSA. The wound healing, histological, and cytokine analyses are conducted to evaluate the efficacy of the helium AP-DBD plasma jet on the MRSA-infected wound healing process. The experimental results show that the helium AP-DBD plasma jet treatment on the wounds infected with MRSA can regulate the secretion of the cytokines, limit the inflammatory response and cell excessive proliferation, accelerate the process of re-epithelialization, and consequently, promote the wound healing process and the inactivation of the bacteria.
Demonstrates altered immune microenvironment in lung adenocarcinoma, indicating therapeutic potential of anlotinib.
BACKGROUND: Vascular endothelial growth factor C (VEGFC), an activator of lymphangiogenesis, is newly identified as an immunomodulator which can regulate the immune system so that tumor cells more easily escape immune surveillance. Evidence has shown programmed cell death-ligand 1 (PD-L1) can also suppress the immune response. Nevertheless, the clinical significance of co-expression of VEGFC and PD-L1 for predicting outcomes in patients with lung adenocarcinoma has not yet been determined. METHODS: A total of 114 patients with lung adenocarcinoma who underwent surgeries at Tianjin Medical University Cancer Institute and Hospital between December 2011 and September 2016 were retrospectively reviewed. Tissue specimens were collected for immunohistochemistry of VEGFC and PD-L1 which were analyzed with an H-score system. RESULTS: In this study, 57 (50.0%) and 47 (41.2%) patients were classified as VEGFC high expression and PD-L1 high expression. Co-expression was observed in 33 (28.9%) patients. In addition, a positive correlation was found between VEGFC and PD-L1 (P = 0.0398, r = 0.1937). In a univariate analysis, both progression-free survival (PFS) and overall survival (OS) were significantly worse in the VEGFC high expression group and the PD-L1 high expression group, respectively. Furthermore, VEGFC/PD-L1 co-expression showed a worse OS (P = 0.03) and PFS survival (P = 0.01) than the other groups. CONCLUSIONS: Taken together, these results indicate that VEGFC/PD-L1 co-expression can forecast both poor OS and PFS in patients with resected lung adenocarcinoma. Co-expression of VEGFC and PD-L1 may serve as a significant prognostic factor for patients with lung adenocarcinoma. KEY POINTS: VEGFC/PD-L1 co-expression forecasts poor survival in patients with resected lung adenocarcinoma. VEGFC/PD-L1 co-expression may be used as a prognostic indicator and provide the theoretical possibility to screen the optimal population with a combination of anti-VEGFC and anti-PD-L1 therapy in the clinical treatment.
activation of the TGFβ1 pathway and upregulation of CD105 expression. Anlotinib reverses the effects of bevacizumab by inhibiting the above signals.
Objective: Lymphatic metastasis is one of the leading causes of malignancy dispersion in various types of cancer. However, few anti-lymphangiogenic drugs have been approved for clinical use to date. Therefore, new therapies to block lymphangiogenesis are urgently required. Methods: Immunohistochemistry, immunofluorescence, Western blot, migration assays, and lymphangiogenesis and lymphatic metastasis assays were used. Results: Anlotinib, a receptor tyrosine kinase inhibitor, suppressed the rate of new metastatic lesions (31.82% in the placebo arm and 18.18% in the anlotinib arm) in patients with advanced lung adenocarcinoma who were enrolled in our ALTER-0303 study. D2-40⁺-lymphatic vessel density was strongly correlated with disease stage, metastasis, and poor prognosis in 144 Chinese patients with lung adenocarcinoma. In mice bearing A549EGFP tumors, tumor lymphatic vessel density, tumor cell migration to lymph nodes, and the number of distant metastatic lesions were lower in the anlotinib group than in the controls. Anlotinib inhibited the growth and migration of human lymphatic endothelial cells (hLECs) and lymphangiogenesis in vitro and in vivo. Treatment of hLECs with anlotinib downregulated phosphorylated vascular endothelial growth factor receptor 3 (VEGFR-3). Conclusions: Anlotinib inhibits lymphangiogenesis and lymphatic metastasis, probably through inactivating VEGFR-3 phosphorylation. The results indicate that anlotinib may be beneficial for treatment in avoiding lymphangiogenesis and distant lymphatic metastasis in lung adenocarcinoma. (Trial registration: ALTER0303; NCT02388919; March 17, 2015.)
Objectives: To elucidate the relationship between VEGFA and PD-L1 expression in lung adenocarcinoma (LADC). Methods: PD-L1 and VEGFA expression were determined by immunohistochemistry with H-score on formalin-fixed paraffin-embedded resected LADC specimens of 129 cases. Results: High PD-L1 expression in 53 (41.1%) patients, high VEGFA expression in 65 (50.4%) and co-expression in 18 (14.0%) were observed. Inverse correlation between expression of PD-L1 and VEGFA was found (P = 0.002, r = -0.274). VEGFA and PD-L1 expression were not significantly associated with the clinicopathological features. High PD-L1 expression was significantly association with all patients’ poor progression-free survival and overall survival in an univariate analysis, but there was no significantly association with high VEGFA expression and prognosis. Co-expression of PD-L1 and VEGFA exhibited a worst overall survival compared to negative groups (P = 0.005). Conclusions: These findings indicate that high PD-L1 expression could forecast both poor overall survival and progression-free survival in patients with resected LADC. Co-expression of PD-L1 and VEGFA may be considered as an important predictor for prognosis of patients with resected lung adenocarcinoma.
Precise control of inclusion and molten steel compositions during ladle-furnace refining is important to obtain high-quality steel. Mass-transfer behavior affects these compositions. A model was developed to investigate the mass transfer occurring between molten steel, slag, inclusions, and the refractory during ladle-furnace refining, using two-film theory to describe the reactions. A coupled-reaction model based on the CaO–Al 2 O 3 –MgO–SiO 2 –FeO–P 2 O 5 slag and Mn–Si–Al–Ca–Mg–P–S–O steel systems was applied to describe the reactions between molten steel and slag; the reactions between the refractory lining and slag or steel were described using average industrial erosion rate data. The model was used to calculate changes in the compositions of molten steel and slag, oxygen activity at the slag–molten steel interface, and composition of the inclusions. The calculated results agreed with operational results for a 100 t ladle furnace at the Tangsteel plant in China.
TiO2-Bi2WO6 binanosheet (TBWO), synthesized by a facile two-step hydrothermal method, was used as an effective visible-light-driven photocatalyst for the inactivation of E. coli and was characterized by TEM, SEM, XRD, FTIR, XPS, and BET. A series of TBWOs with different doping ratios of TiO2 loading from 10 to 55 wt % were synthesized. Among all of the TBWOs, 40% TBWO exhibited the best bacteria disinfection efficiency, and the quantity of viable bacteria could reach 10° with 40% TBWO (100 μg/mL) after being illuminated for 4 h. Furthermore, the confocal fluorescent-based cell live/dead test and the SEM technology were applied to verify the photocatalytically lethal effect toward E. coli and the rupture of bacterial membranes. The leak of bacterial contents, including the bacterial genome represented by relevant 16srDNA, and total protein were detected by PCR and bicinchoninic acid assay. In this work, the antibacterial mechanism was studied by employing photoelectrochemical techniques, electron spin resonance (ESR), and scavengers of different reactive species, revealing the pivotal roles of electron hole (h(+)) and electron (e(-)) in the photocatalytic process. In addition, the •O2(-) and •OH radicals were also detected in the TBWOs system by ESR. It was found that the adsorption of visible light and separation of photogenerated carriers within TiO2 have been largely promoted after being coupled with Bi2WO6, which should be responsible for the improved bactericidal effect.
Fe3O4-TiO2 nanosheets (Fe3O4-TNS) were synthesized by means of lamellar reverse micelles and solvothermal method, which were characterized by TEM, XRD, XPS, BET, and magnetic property analysis. It can be found that Fe3O4-TNS nanosheets exhibited better photocatalytic antibacterial activity toward Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus than pure Fe3O4 and TNS, and the antibacterial efficiency could reach 87.2% and 93.7% toward E. coli and S. aureus with 100 μg/mL Fe3O4-TNS after 2 h of simulated solar light illumination, respectively. The photocatalytic destruction of bacteria was further confirmed by fluorescent-based cell live/dead test and SEM images. It was uncovered that Fe3O4-TNS inactivated G- E. coli and G+ S. aureus by different mechanisms: the destruction of outer membranes and ruptured cell bodies were responsible for the bactericidal effect against E. coli, while the antibacterial effect toward S. aureus were due to the fact that the cells were adsorbed in form of clusters by massive Fe3O4-TNS, which could restrict their activities and cause malfunction of the selective permeable barriers. Furthermore, the antibacterial mechanism was studied by employing scavengers to understand exact roles of different reactive species, indicating the key roles of h(+) and H2O2. The recovery and reusability experiments indicated that Fe3O4-TNS still retained more than 90% bacteria removal efficiency even after five cycles. Considering the easy magnetic separation, bulk availability, and high antibacterial activity of Fe3O4-TNS, it is a promising candidate for cleaning the microbial contaminated water environment.
Ag-CoFe2O4-graphene oxide (Ag-CoFe2O4-GO) nanocomposite was synthesized by doping silver and CoFe2O4 nanoparticles on the surface of GO, which was used to purify both bacteria and Pb(II) contaminated water. The Ag-CoFe2O4-GO nanomaterial was characterized by transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), Raman, X-ray photoelectron spectroscopy (XPS), Brunauer-Emmett-Teller (BET), cyclic voltammetry (CV), and magnetic property tests. It can be found that Ag-CoFe2O4-GO nanocomposite exhibited excellent antibacterial activity against Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus compared with CoFe2O4, Ag-CoFe2O4, and CoFe2O4-GO composite. This superior disinfecting effect was possibly attributed to the combination of GO nanosheets and Ag nanoparticles. Several antibacterial factors including temperature, time, and pH were also investigated. It was obvious that E. coli was more susceptible than S. aureus toward all the four types of nanomaterials. The structural difference of bacterial membranes should be responsible for the resistant discrepancy. We also found that Ag-CoFe2O4-GO inactivated both bacteria in an irreversibly stronger manner than Ag-CoFe2O4 and CoFe2O4-GO. The Pb(II) removal efficiency with all the nanomaterials showed significant dependence on the surface area and zeta potential of the materials. In this work, not only did we demonstrate the simultaneous superior removal efficiency of bacteria and Pb(II) by Ag-CoFe2O4-GO but also the antibacterial mechanism was discussed to have a better understanding of the interaction between Ag-CoFe2O4-GO and bacteria. In a word, taking into consideration the easy magnetic separation, bulk availability, and irreversibly high antibacterial activity of Ag-CoFe2O4-GO, it is the very promising candidate material for advanced antimicrobial or Pb(II) contaminated water treatment.
Magnetic Fe3O4/graphene composite (abbreviated as G-Fe3O4) was synthesized successfully by solvothermal method to effectively remove both bacteriophage and bacteria in water, which was tested by HRTEM, XRD, BET, XPS, FTIR, CV, magnetic property and zeta-potential measurements. Based on the result of HRTEM, the single-sheet structure of graphene oxide and the monodisperse Fe3O4 nanoparticles on the surface of graphene can be observed obviously. The G-Fe3O4 composite were attractive for removing a wide range of pathogens including not only bacteriophage ms2, but also various bacteria such as S. aureus, E. coli, Salmonella, E. Faecium, E. faecalis, and Shigella. The removal efficiency of E. coli for G-Fe3O4 composite can achieve 93.09%, whereas it is only 54.97% with pure Fe3O4 nanoparticles. Moreover, a detailed verification test of real water samples was conducted and the removal efficiency of bacteria in real water samples with G-Fe3O4 composite can also reach 94.8%.
Photo darkening was observed in epitaxial InGaAs/GaAs quantum dots (QDs). The photoluminescence (PL) intensity of the QDs showed a non-reversible decrease under continuous laser irradiation. The time constants varied from tens of minutes to several hours, depending on the applied laser power. Based on the spectral evolution, it was concluded that the observed phenomenon should originate from laser induced structural damage and a sustained increase of non-radiative recombination rate in the wetting layer. Additionally, according to the PL decay dynamics at different laser powers, it is argued that there should exist other processes that hinder PL degradation at a high laser power.